This message contains My NCBI what's new results from the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).
Do not reply directly to this message.

Sender's message: Search: MULTIPLE SCLEROSIS

1:	Inglis JJ, Criado G, Andrews M, Feldmann M, Williams RO, Selley ML.	Related Articles
	The anti-allergic drug, N-(3',4'-dimethoxycinnamonyl) anthranilic acid, exhibits potent anti-inflammatory and analgesic properties in arthritis. Rheumatology (Oxford). 2007 Jul 21; [Epub ahead of print] PMID: 17644821 [PubMed - as supplied by publisher]

2:	Zujovic V, Bachelin C, Baron-Van Evercooren A.	Related Articles
	Remyelination of the central nervous system: a valuable contribution from the periphery. Neuroscientist. 2007 Aug;13(4):383-91. PMID: 17644768 [PubMed - in process]

3:	Schrempf W, Ziemssen T.	Related Articles
	Glatiramer acetate: Mechanisms of action in multiple sclerosis. Autoimmun Rev. 2007 Aug;6(7):469-75. Epub 2007 Mar 6. PMID: 17643935 [PubMed - in process]

4:	Kuipers HF, van den Elsen PJ.	Related Articles
	Immunomodulation by statins: Inhibition of cholesterol vs. isoprenoid biosynthesis. Biomed Pharmacother. 2007 Jul 5; [Epub ahead of print] PMID: 17643927 [PubMed - as supplied by publisher]

5:	Kassmann CM, Lappe-Siefke C, Baes M, Brugger B, Mildner A, Werner HB, Natt O, Michaelis T, Prinz M, Frahm J, Nave KA.	Related Articles
	Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat Genet. 2007 Jul 22; [Epub ahead of print] PMID: 17643102 [PubMed - as supplied by publisher]

6:	Flechter S, Vardi J, Finkelstein Y, Pollak L.	Related Articles
	Cognitive dysfunction evaluation in multiple sclerosis patients treated with interferon beta-1b: an open-label prospective 1 year study. Isr Med Assoc J. 2007 Jun;9(6):457-9. PMID: 17642394 [PubMed - in process]